New sedative may offer safer heart scans
NCT ID NCT06129188
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study tested a new FDA-approved sedative, remimazolam, against the standard drug propofol for patients having a heart imaging test called TEE. The goal was to see if remimazolam provides better blood pressure stability and faster recovery. 105 adults participated, and researchers measured vital signs and sedation levels during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Alabama at Birmingham Hospital
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.